Abstract:Importance: The clinical outcomes associated with masked hypertension defined by home blood pressure monitoring (HBPM) in clinical settings remain uncertain.Objective: To assess the association between masked hypertension and cardiovascular disease events in clinical settings.Design, Setting, and Participants: This observational cohort study used data from 4261 outpatients treated at 71 primary practices or university hospitals throughout Japan who were enrolled in the Japan Morning Surge-Home Blood Pressure study between January 1, 2005, and December 31, 2012. Participants had a history of or risk factors for cardiovascular disease and were followed up through March 31, 2015. Participants underwent clinic blood pressure (BP) measurements on 2 occasions as well as HBPM measurements in the morning and evening for a 14-day period. Urine albumin to creatinine ratio and circulating brain (or B-type) natriuretic peptide levels were quantified at baseline as a marker of cardiovascular end-organ damage. Data were analyzed from July 1, 2017, to October 31, 2017.Exposures: Participants were categorized into 4 BP groups: (1) masked hypertension-hypertensive home BP levels (systolic, ≥135 mm Hg; diastolic, ≥85 mm Hg) and nonhypertensive clinic BP levels (systolic, <140 mm Hg; diastolic, <90 mm Hg); (2) white-coat hypertension-nonhypertensive home BP levels (systolic, <135 mm Hg; diastolic, <85 mm Hg) and hypertensive clinic BP levels (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg); (3) sustained hypertension-hypertensive home and clinic BP levels; and (4) controlled BP-nonhypertensive home and clinic BP levels.Main Outcomes and Measures: Incident stroke and coronary heart disease.Results: Of the 4261 participants, 2266 (53.2%) were women, 3374 (79.2%) were taking antihypertensive medication, and the mean (SD) age was 64.9 (10.9) years. During a median (interquartile range) follow-up of 3.9 (2.4-4.6) years, 74 stroke (4.4 per 1000 person-years) and 77 coronary heart disease (4.6 per 1000 person-years) events occurred. The masked hypertension group had a greater risk for stroke compared with the controlled BP group (hazard ratio, 2.77; 95% CI, 1.20-6.37), independent of traditional cardiovascular risk factors, urine albumin to creatinine ratio, and circulating B-type natriuretic peptide levels. Conversely, masked hypertension yielded no association with coronary heart disease risk.Conclusions and Relevance: In the Japanese general practice population, masked hypertension defined by HBPM may be associated with an increased risk for stroke events. Use of HBPM may improve the assessment of BP-related risks and identify new therapeutic interventions aimed at preventing cardiovascular disease events.

White Coat Hypertension & Cardiovascular Outcomes

White-coat hypertension in adults

Current status of white coat hypertension: where are we?

["White coat" hypertension in primary care. Study using ambulatory blood pressure monitoring]

Blood Pressure Out of the Office: Its Time Has Finally Come

Blood pressure and heart rate variability and baroreflex sensitivity in white-coat, masked, and sustained hypertension

Status of ambulatory blood pressure monitoring and home blood pressure monitoring for the diagnosis and management of hypertension in the US: an up-to-date review

Relationship between white-coat hypertension and office isolated systolic or diastolic hypertension: an ambulatory blood pressure monitoring study

The impact of physician vs automated blood pressure readings on office-induced hypertension

A short note on hypertension management

White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Is remote blood pressure monitoring and management a better approach for patients with hypertension? A narrative review

Resistant Hypertension and Mortality: An Observational Cohort Study

Perception and Self-Management of Hypertension in Chinese Cardiologists (CCHS): a Multicenter, Large-Scale Cross-Sectional Study

Outpatient management of essential hypertension: a review based on the latest clinical guidelines

Peripheral White Blood Cells and Blood Pressure

ARTERIAL STIFFNESS AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH WHITE COAT HYPERTENSION

The role of wearable home blood pressure monitoring in detecting out-of-office control status

Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life

White-coat hypertension during coronary computed tomography angiography is associated with higher coronary atherosclerotic burden